Published in Scand J Psychol on February 18, 2011
Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation. Eur Arch Psychiatry Clin Neurosci (2014) 1.01
IL-6 regulation of synaptic function in the CNS. Neuropharmacology (2014) 0.91
Depiction of microglial activation in aging and dementia: Positron emission tomography with [(11)C]DPA713 versus [(11)C]( R)PK11195. J Cereb Blood Flow Metab (2016) 0.78
Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins. Front Cell Neurosci (2014) 0.76
Curcumin Mimics the Neurocognitive and Anti-Inflammatory Effects of Caloric Restriction in a Mouse Model of Midlife Obesity. PLoS One (2015) 0.76
Association of cognitive performance with interleukin-6 receptor Asp358Ala polymorphism in healthy adults. J Neural Transm (Vienna) (2011) 0.75
Stability, growth, and decline in adult life span development of declarative memory: cross-sectional and longitudinal data from a population-based study. Psychol Aging (2005) 2.99
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes (2004) 2.17
Structure-function correlates of cognitive decline in aging. Cereb Cortex (2005) 2.16
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol (2006) 2.16
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology (2002) 1.82
Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation (2004) 1.67
The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension (2004) 1.59
Slight increase of serum S-100B during porcine endotoxemic shock may indicate blood-brain barrier damage. Anesth Analg (2005) 1.57
The memory-enhancing effects of Ginseng and Ginkgo biloba in healthy volunteers. Psychopharmacology (Berl) (2003) 1.51
Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest (2002) 1.48
Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain (2006) 1.39
Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma. Ann N Y Acad Sci (2007) 1.35
Self-rated health is related to levels of circulating cytokines. Psychosom Med (2004) 1.34
Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett (2006) 1.31
Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry (2011) 1.31
COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet (2004) 1.31
Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2007) 1.30
High prevalence of white matter hyperintensities in normal aging: relation to blood pressure and cognition. Cortex (2003) 1.29
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther (2009) 1.29
Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J Cogn Neurosci (2005) 1.26
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis (2005) 1.26
Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls. Clin Chem Lab Med (2006) 1.25
Blood-brain barrier alterations in ageing and dementia. J Neurol Sci (2009) 1.24
Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr (2003) 1.23
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry (2005) 1.23
Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr (2005) 1.22
Longitudinal evidence for diminished frontal cortex function in aging. Proc Natl Acad Sci U S A (2010) 1.22
Longitudinal data for interdisciplinary ageing research. Design of the Linnaeus Database. Scand J Public Health (2010) 1.20
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol (2005) 1.20
Calibration of the Siemens cystatin C immunoassay has changed over time. Clin Chem (2011) 1.16
Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am J Clin Nutr (2008) 1.16
Does singing promote well-being?: An empirical study of professional and amateur singers during a singing lesson. Integr Physiol Behav Sci (2003) 1.16
Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. Chem Senses (2004) 1.14
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther (2012) 1.11
Genetic and lifestyle predictors of 15-year longitudinal change in episodic memory. J Am Geriatr Soc (2012) 1.10
The multifold relationship between memory and decision making: an individual-differences study. J Exp Psychol Learn Mem Cogn (2013) 1.10
Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. J Gerontol B Psychol Sci Soc Sci (2007) 1.07
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers. J Alzheimers Dis (2013) 1.07
Influence of COMT gene polymorphism on fMRI-assessed sustained and transient activity during a working memory task. J Cogn Neurosci (2010) 1.06
Hearing loss is negatively related to episodic and semantic long-term memory but not to short-term memory. J Speech Lang Hear Res (2010) 1.06
The Hypomania Checklist (HCL-32): its factorial structure and association to indices of impairment in German and Swedish nonclinical samples. Compr Psychiatry (2006) 1.05
Selective adult age differences in an age-invariant multifactor model of declarative memory. Psychol Aging (2003) 1.05
Executive functioning in older adults with mild cognitive impairment: MCI has effects on planning, but not on inhibition. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2007) 1.05
Sequencing of DISC1 pathway genes reveals increased burden of rare missense variants in schizophrenia patients from a northern Swedish population. PLoS One (2011) 1.05
A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry (2003) 1.04
Age-related white matter microstructural differences partly mediate age-related decline in processing speed but not cognition. Biochim Biophys Acta (2011) 1.03
Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis (2004) 1.02
Sex differences in cognition are stable over a 10-year period in adulthood and old age. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2006) 1.02
The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin Chim Acta (2004) 1.02
Cerebral changes on MRI and cognitive function: the CASCADE study. Neurobiol Aging (2006) 1.01
Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol (2004) 1.00
The stress of birth enhances in vitro spontaneous and IL-8-induced neutrophil chemotaxis in the human newborn. Pediatr Allergy Immunol (2007) 1.00
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry (2008) 0.97
Beta-amyloid protein structure determines the nature of cytokine release from rat microglia. J Mol Neurosci (2005) 0.97
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Dement Geriatr Cogn Disord (2009) 0.96
Rapid activation of haemostasis after hormonal emergency contraception. Thromb Haemost (2007) 0.95
Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med (2005) 0.95
Longitudinal structure-function correlates in elderly reveal MTL dysfunction with cognitive decline. Cereb Cortex (2011) 0.95
KIBRA polymorphism is related to enhanced memory and elevated hippocampal processing. J Neurosci (2011) 0.95
Selective sex differences in declarative memory. Mem Cognit (2004) 0.95
Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro. FEBS J (2007) 0.94
The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med (2014) 0.94
Increased glucose levels are associated with episodic memory in nondiabetic women. Diabetes (2007) 0.94
Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis. Arterioscler Thromb Vasc Biol (2002) 0.94
How do health and biological age influence chronological age and sex differences in cognitive aging: moderating, mediating, or both? Psychol Aging (2006) 0.94
Parietal cortex activation predicts memory decline in apolipoprotein E-epsilon4 carriers. Neuroreport (2006) 0.93
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study. PLoS One (2012) 0.93
Sex differences in recollective experience for olfactory and verbal information. Acta Psychol (Amst) (2003) 0.93
Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4. Behav Genet (2009) 0.93
Brain characteristics of individuals resisting age-related cognitive decline over two decades. J Neurosci (2013) 0.93
Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease. Neurochem Int (2005) 0.92
Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand (2008) 0.92
Flynn effects on sub-factors of episodic and semantic memory: parallel gains over time and the same set of determining factors. Neuropsychologia (2008) 0.92
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol (2005) 0.92
What people believe about memory. Memory (2006) 0.92
Psychosocial working conditions and cognitive complaints among Swedish employees. PLoS One (2013) 0.92
Cognitive and non-cognitive factors contributing to the longitudinal identification of successful older adults in the betula study. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2007) 0.92
Impaired long term memory consolidation in transgenic mice overexpressing the human soluble form of IL-1ra in the brain. J Neuroimmunol (2009) 0.91
Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse. Acta Neuropathol (2004) 0.91
Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B. Acta Neurochir (Wien) (2010) 0.91
Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. Eur J Neurosci (2008) 0.91
alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides (2006) 0.91
Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden. Clin Chem Lab Med (2015) 0.91
Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay. Int J Oncol (2009) 0.90
APOE ε4 is associated with longer telomeres, and longer telomeres among ε4 carriers predicts worse episodic memory. Neurobiol Aging (2010) 0.90
Cigarette smoking and cognitive performance in healthy Swedish adults. Age Ageing (2003) 0.90
Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J (2005) 0.90
Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiol Aging (2008) 0.90
Comparison of cardiovascular prognosis by 3 serum cystatin C methods in the Heart and Soul Study. Clin Chem (2011) 0.90
Allopregnanolone impairs episodic memory in healthy women. Psychopharmacology (Berl) (2008) 0.89
Elevated blood levels of dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in Sweden. Psychother Psychosom (2002) 0.89
Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment. Ups J Med Sci (2004) 0.89
Natural teeth and cognitive function in humans. Scand J Psychol (2007) 0.89
A longitudinal study of memory advantages in bilinguals. PLoS One (2013) 0.89
Traffic-Related Air Pollution and Dementia Incidence in Northern Sweden: A Longitudinal Study. Environ Health Perspect (2015) 0.88
Subjective health perception in healthy young men changes in response to experimentally restricted sleep and subsequent recovery sleep. Brain Behav Immun (2013) 0.88
Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility. BMC Nephrol (2013) 0.88